An Open Study of Tipepidine Hibenzate in Patients With Attention Deficit Hyperactivity Disorder (ADHD)
NCT01835093
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Attention Deficit Disorder With Hyperactivity
Interventions
DRUG:
Tipepidine Hibenzate
Sponsor
Chiba University